Recently, Fosun Beiling and Zhijiang Biological signed a business cooperation agreement to jointly develop and produce "automatic P2+ nucleic acid detection vehicle". Fosun Beiling provides BLS-2+ laboratory modification for cooperative products. The negative pressure experimental area adopts full fresh air directional flow design, and the mobile testing platform from non-contact sampling to fully automated testing opens up the last 100m of the township, realizing instant sampling and inspection, and the whole process can produce results in two hours at the fastest.
▲ Fully automatic P2+ nucleic acid detection car
P2+ mobile laboratory has made great contributions during the epidemic, it can minimize the movement of potentially infected people, complete the detection and screening of various indicators, and can reduce the detection process and detection cycle; In addition, the product can solve the risk of long-distance collection of pathogenic microorganisms and intermediate route infection, and can be quickly analyzed at the collection site.
In early 2020, with the outbreak of the novel coronavirus pneumonia, Fosun Beiling, relying on years of product development technology and experienced engineers, quickly transformed the accumulated results of daily research and development into practical applications. So far, it has provided a series of "P2+ nucleic acid detection vehicle" related products and pathogenic microorganism detection solutions to Beijing CDC, Shandong Linyi CDC, Shaanxi Baoji CDC, Guangxi Autonomous Region CDC, Hubei Shiyan CDC, and Hohhot Customs in Inner Mongolia.
In addition, in order to support the national prevention and control of the novel coronavirus pneumonia epidemic, Fosun Beiling also undertook nucleic acid testing tasks. The "Fosun Beiling Anti-epidemic Team" established in October this year, combined with the advantages of Fosun member enterprises and other resources, quickly deployed a number of mobile shelters from across the country, and completed a total of 1.96 million testing tasks, contributing to winning the epidemic prevention and control war in Zunyi City.
Facing the future, Fosun Beiling will continue to deepen the field of public health, accelerate the deep integration of technology and scene, constantly explore and innovate, and commit to providing more intelligent products and services for partners, creating a more brilliant tomorrow!
About Fosun Beiling
Fosun Beiling (Beijing) Medical Technology Co., Ltd. is a core member of Fosun Medical Device sector. Adhere to the "protect life with science and technology", relying on digital technology and mobile medical platform as the carrier, integrate all on-board medical equipment, build independent research and development system, create the country's leading smart mobile medical digital platform, provide customers with professional special vehicles and medical equipment overall solution, committed to becoming a domestic leader in the field of pre-hospital emergency and critical illness. To support the development of China's public health, emergency rescue and critical illness diagnosis and treatment industries.
About Zhijiang biology
Established in 2005, Shanghai Zhijiang Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, production and sales of genetic diagnostic reagents and instruments, and is one of the leading enterprises in the production of molecular diagnostic reagents in China.
